NH - ナチュラル・ヘルス・トレンズ (NantHealth Inc.)

NHのニュース

   Head to Head Review: Marathon Digital (NASDAQ:MARA) & NantHealth (NASDAQ:NH)  2021/12/23 06:20:42 Transcript Daily
Marathon Digital (NASDAQ:MARA) and NantHealth (NASDAQ:NH) are both business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, earnings, risk and institutional ownership. Volatility & Risk Marathon Digital has a beta of 4.73, meaning that its share price is […]
   NantHealth (NASDAQ:NH) Issues Earnings Results, Misses Estimates By $0.02 EPS  2021/11/07 17:06:41 Dakota Financial News
NantHealth (NASDAQ:NH) announced its earnings results on Thursday. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the Zacks consensus estimate of ($0.08) by ($0.02), MarketWatch Earnings reports. During the same quarter in the prior year, the company earned ($0.08) EPS. Shares of NH stock traded up $0.08 on Friday, reaching $1.77. []
   NantHealth, Inc. Common Stock (NH) Q3 2021 Earnings Call Transcript  2021/11/05 18:31:51 The Motley Fool
NH earnings call for the period ending September 30, 2021.
   NantHealth EPS misses by $0.02, misses on revenue  2021/11/04 21:34:00 Seeking Alpha
   NantHealth to Participate at the 2021 Jefferies London Healthcare Conference  2021/11/04 20:07:00 Business Wire
MORRISVILLE, N.C.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that the company will participate at the 2021 Jefferies London Healthcare Conference. Management plans to host virtual one-on-one and small group meetings with institutional investors on November 18 and 19, 2021. For additional information or to schedule a meeting with NantHealth management, please
   NantHealth Consensus Indicates Potential 101.1% Upside  2021/10/22 09:44:21 DirectorsTalk
NantHealth with ticker code (NH) now have 2 analysts covering the stock. The analyst consensus points to a rating of ''None''. The target price ranges between 4 and 3 with a mean TP of 3.5. Given that the stocks previous close was at 1.74 this would imply there is a potential upside of 101.1%. The 50 day MA is 1.79 while the 200 day moving average is 2.25. The market capitalisation for the company is $207m. You can visit the company''s website by visiting: /> [stock_market_widget type="chart" symbol="NH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] NantHealth, together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform''s comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions.
   NantHealth Teams Up with Care Continuity for Patient Navigation and Care Coordination Across the Healthcare Continuum  2021/10/18 13:00:00 Business Wire
MORRISVILLE, N.C. & DALLAS--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced an agreement with Care Continuity Inc., a leader in network integrity and care navigation across the care continuum. The agreement was formed to improve the management of care logistics for complex, high risk and chronic diseases. The care pathways enabled by this collaboration will support
   NantHealth (NH) Downgraded by Zacks Investment Research to Hold  2021/10/13 15:34:00 Stock Market Daily
NantHealth} stock has undergone multiple analysts rating changes in the recent past. NantHealth Downgraded by Zacks Investment Research on 10/13/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy. The post NantHealth (NH) Downgraded by Zacks Investment Research to Hold appeared first on .
   Future Trend of Medical Device Interoperability Market by Regions, Type, Application, Forecast (2021-2030) with Leading Players- NantHealth Inc., Bernoulli Enterprise Inc., iHealth Lab Inc.  2021/09/14 13:40:57 OpenPR
The research report titled as, Medical Device Interoperability Market has recently added by Absolute Markets Insights to its massive database which offers a clear understanding of various business aspects of the Medical Device Interoperability market. This research report has been
   Global HealthTech Startups Market Top Growing Companies Analysis and Segmentation Outlook till 2028| TechCrunch, Sosido Networks Inc, QxMD, eKinCare, NantHealth  2021/09/09 12:35:07 OpenPR
The Recent exploration on Global HealthTech Startups Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, forecast to 2028" offered by QY Reports, Industry is an extensive report that gives select bits of knowledge about HealthTech Startups business
   NantHealth, Inc. (NH) Management on Q2 2021 Results - Earnings Call Transcript  2021/08/06 02:50:43 Seeking Alpha
   NantHealth EPS beats by $0.02, misses on revenue  2021/08/05 20:32:18 Seeking Alpha
   NantHealth Reports 2021 Second Quarter Financial Results  2021/08/05 20:05:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its second quarter ended June 30, 2021. Our 2021 second-quarter financial results were in-line with our expectations and remained steady compared with the previous quarter, said Ron Louks, Chief Operating Officer, NantHealth. "We are focused on investing in our business through the
   NantHealth picks internal candidate for medical chief  2021/08/03 13:40:26 Seeking Alpha
   Future Trend & Forecast of Medical Device Interoperability Market by Regions, Type, Application, Forecast (2021-2030) with Leading Players- NantHealth Inc., Bernoulli Enterprise Inc., iHealth Lab Inc.  2021/08/03 11:29:19 OpenPR
The research report titled as, Medical Device Interoperability Market has recently added by Absolute Markets Insights to its massive database which offers a clear understanding of various business aspects of the Medical Device Interoperability market. This research report has been

calendar